What is the growth forecast for the in vitro diagnostics market?

The market is expected to grow at a CAGR of 8.1% from 2023 to 2028, driven by increasing demand.

What are the key drivers of the in vitro diagnostics ivd products test market?

Key drivers include rising healthcare expenditures, technological advancements, and an aging population.

What are the major challenges facing the in vitro diagnostics market?

Challenges include regulatory hurdles, reimbursement issues, and intense competition among manufacturers.

Which regions are leading the in vitro diagnostics ivd products test market?

North America and Europe are leading the market, due to well-established healthcare infrastructure.

Who are the top companies in the in vitro diagnostics market?

Top companies include Roche, Abbott, and Siemens, which offer a wide range of diagnostic products.

What are the future opportunities in the in vitro diagnostics ivd products test market?

Future opportunities include emerging markets, point-of-care diagnostics, and personalized medicine.

How will technology impact the in vitro diagnostics market future outlook?

Technological advancements, such as AI and genomics, will drive innovation and growth in the market.

What is the current regulatory landscape for the in vitro diagnostics market?

The regulatory landscape is complex, with varying requirements across regions, and manufacturers must comply.

How will the in vitro diagnostics ivd products test market evolve in the next 5 years?

The market will evolve through increased adoption of digital diagnostics, and expansion into emerging markets.

Which Companies Lead the in vitro diagnostics ivd products test Market in 2026?

in vitro diagnostics ivd products test by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

in vitro diagnostics ivd products test Market Size | CAGR 10.2 Forecast 2033

Which Companies Lead the in vitro diagnostics ivd products test Market in 2026?

in vitro diagnostics ivd products test by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $123.4 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

in vitro diagnostics ivd products test Market Overview

The in vitro diagnostics (IVD) products test market refers to the industry that provides medical testing and diagnostic solutions outside a living organism. The relevance of this market lies in its critical role in enabling healthcare professionals to diagnose and monitor diseases accurately. As we delve into the in vitro diagnostics IVD products test market size, growth outlook, market forecast, and industry expansion, it is essential to understand the scope of this market, which encompasses various diagnostic tests, medical devices, and laboratory equipment. The current in vitro diagnostics IVD products test market size is approximately $83.8 billion, according to recent market research. The market is expected to witness a significant growth forecast, with a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2026 to 2033, driven by macro drivers such as an increasing prevalence of chronic diseases, technological advancements, and rising demand for point-of-care testing.

Loading chart…

Several key forces are shaping the in vitro diagnostics IVD products test market, including technology shifts towards point-of-care testing and molecular diagnostics, regulations such as the In Vitro Diagnostic Regulation (IVDR) in Europe, and consumer behavior driven by increasing awareness of preventive care. The largest region in the in vitro diagnostics IVD products test market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and infrastructure development. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities to remain competitive and drive industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	268.39 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Becton Dickinson Company; bioMerieux SA; F. Hoffmann-La Roche Ltd.; Siemens Healthcare; Alere Inc; Beckman Coulter, Inc.; Bio-Rad Laboratories; Hologic; Ortho Clinical Diagnostics; Roche Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The in vitro diagnostics ivd products test market is experiencing significant transformations, driven by technological advancements, regulatory changes, and shifting demand patterns. Understanding the market dynamics is crucial for strategy leaders, business development heads, and C-suite executives to navigate this complex landscape.

Growth Drivers2 items

Advances in genomics and proteomics are fueling the development of innovative in vitro diagnostics ivd products test market solutions, enabling early disease detection and personalized medicine. This, in turn, is driving the growth forecast of the market.

Increasing demand for point-of-care testing is another key driver, as it enhances patient outcomes, reduces healthcare costs, and improves the overall efficiency of diagnostic processes, ultimately contributing to the expansion of the in vitro diagnostics ivd products test market size.

Restraints2 items

Stringent regulatory requirements and the need for compliance with international standards can hinder the growth of the in vitro diagnostics ivd products test market, particularly for smaller manufacturers and new entrants.

The high cost of research and development in the in vitro diagnostics ivd products test market can limit innovation, especially for companies with limited financial resources, thus affecting the overall growth forecast of the market.

Opportunities2 items

The emerging markets present significant opportunities for the in vitro diagnostics ivd products test market, driven by increasing healthcare expenditure, growing awareness about preventive care, and the need for advanced diagnostic solutions, which will contribute to the in vitro diagnostics ivd products test market size.

The integration of artificial intelligence and machine learning in in vitro diagnostics is expected to enhance the accuracy, speed, and efficiency of diagnostic tests, creating new avenues for growth and innovation in the in vitro diagnostics ivd products test market.

Challenges2 items

The in vitro diagnostics ivd products test market faces challenges related to data privacy and security, as diagnostic tests increasingly rely on sensitive patient information and digital platforms, which must be protected to maintain trust and compliance with regulations.

The global supply chain disruptions can impact the availability and affordability of in vitro diagnostics ivd products, affecting the ability of healthcare systems to provide timely and effective diagnostic services, and thus influencing the growth forecast of the in vitro diagnostics ivd products test market.

Market Segmentation

Loading chart…

The in vitro diagnostics ivd products test segmentation is categorized based on application, which includes clinical chemistry, molecular diagnostics, immunodiagnostics, and hematology. Each segment contributes to the overall market size, with clinical chemistry holding a significant share. This segment includes tests for measuring various chemical components in the blood, such as glucose and cholesterol levels. The clinical chemistry segment is further divided into sub-segments, including basic metabolic panels and liver panels.

The molecular diagnostics segment is another significant contributor to the in vitro diagnostics ivd products test market size. This segment includes tests that detect and identify specific genetic sequences or mutations, such as those associated with infectious diseases or cancer. The molecular diagnostics segment is driven by advances in technology, including polymerase chain reaction (PCR) and next-generation sequencing (NGS). The segment is further divided into sub-segments, including infectious disease testing and oncology testing.

The immunodiagnostics segment includes tests that measure the levels of specific antibodies or antigens in the blood, such as those associated with autoimmune disorders or allergies. This segment is driven by the increasing prevalence of chronic diseases and the need for accurate diagnosis and monitoring. The immunodiagnostics segment is further divided into sub-segments, including autoimmune disease testing and allergy testing. Understanding the in vitro diagnostics ivd products test segmentation is crucial for industry players to develop targeted strategies and products.

The hematology segment includes tests that measure various components of the blood, such as red and white blood cell counts, hemoglobin levels, and blood clotting factors. This segment is driven by the increasing prevalence of blood disorders, such as anemia and leukemia. The hematology segment is further divided into sub-segments, including complete blood counts (CBCs) and coagulation testing. The in vitro diagnostics ivd products test market is expected to grow significantly in the coming years, driven by advances in technology and the increasing demand for accurate diagnosis and monitoring.

Regional Insights

Loading chart…

The in vitro diagnostics ivd products test market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 35% of the global market, driven by key drivers such as high adoption of advanced diagnostic technologies, favorable policies and investments in healthcare infrastructure, and a mature ecosystem.

Asia Pacific is the fastest-growing region, with a regional forecast indicating a significant surge in demand for in vitro diagnostics ivd products. The region's growth can be attributed to key drivers such as increasing demographics and infrastructure development, rising investments in healthcare, and growing awareness about the importance of early disease diagnosis.

Europe, Latin America, and Middle East & Africa are also expected to contribute to the in vitro diagnostics ivd products test market growth, with key drivers such as adoption of point-of-care diagnostic devices, implementation of policies to improve healthcare access, and increasing investments in research and development. The ecosystem maturity of these regions will play a crucial role in shaping the market landscape.

Competitive Landscape

The in vitro diagnostics ivd products test market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The in vitro diagnostics ivd products test competitive landscape is driven by companies that have successfully navigated these levers to establish a strong presence. Global players have a significant share, but local companies also have a notable presence, particularly in emerging markets.

Companies are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They are focusing on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are responding by adapting their strategies to address these challenges and maintain their market position.

Abbott Laboratories: regional expansion

Becton Dickinson Company: vertical integration

bioMerieux SA: premium pricing

F. Hoffmann-La Roche Ltd.: innovation pipeline

Siemens Healthcare: local manufacturing

Alere Inc: OEM tie-ups

Key in vitro diagnostics ivd products test Companies11 items

Abbott Laboratories

Becton Dickinson Company

bioMerieux SA

F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Alere Inc

Beckman Coulter, Inc.

Bio-Rad Laboratories

Hologic

Ortho Clinical Diagnostics

Roche Diagnostics

Market Ecosystem

The in vitro diagnostics ivd products test ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and used by end users. Value is created and captured at each stage, with technology providers and suppliers influencing the development of products, and end users driving demand.

Raw material/component suppliers — provide essential inputs

OEMs / manufacturers — produce in vitro diagnostics products

Technology providers — develop underlying technologies

System integrators / EPCs — integrate products into larger systems

Distributors / channel partners — bring products to market

Regulators/standards bodies — set standards and approvals

End users / buyers — drive demand and adoption

Control points in the in vitro diagnostics ivd products test ecosystem are primarily held by regulators and end users, who influence adoption through standards and demand. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and quality of products. Switching costs and partnerships are also important considerations, as they can affect the ability of participants to adapt to changing market conditions. Furthermore, interoperability requirements can pose significant challenges, particularly in regions with diverse regulatory frameworks, highlighting the need for a comprehensive value chain analysis to navigate the complex in vitro diagnostics ivd products test ecosystem.

Recent Industry Insights

The in vitro diagnostics (IVD) products test industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between major IVD companies and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, leading to consolidation and expansion of product portfolios. Furthermore, several product/technology launches have been announced, focusing on advanced diagnostic techniques and point-of-care testing solutions.

Additionally, regulatory changes have impacted the in vitro diagnostics IVD products test industry trends, with updates to guidelines and standards for IVD product approval and commercialization. Shifts in consumer and enterprise trends have also been observed, with increased demand for personalized medicine and digital health solutions. Funding rounds and expansions have been secured by several IVD companies, enabling them to invest in research and development, and enhance their market presence.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the in vitro diagnostics ivd products test market. The market attractiveness is driven by the increasing demand for accurate and rapid diagnostic tests, fueled by the growing burden of chronic diseases. The competitive intensity is high, with key players investing heavily in research and development to stay ahead in the market. The long-term outlook for the in vitro diagnostics ivd products test market outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in technologies such as point-of-care testing and molecular diagnostics. However, the demand-supply balance is a key challenge, with some regions facing shortages of essential diagnostic tests. Key risk factors include regulatory changes, supply chain disruptions, and intense competition. Overall, the market offers opportunities for growth and innovation, but companies must be strategic in their approach to navigate the complex landscape and capitalize on the emerging trends in the in vitro diagnostics ivd products test market.

11 items

1. Executive Summary

2. in vitro diagnostics ivd products test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global in vitro diagnostics ivd products test Market Outlook & Forecast (2021-2033) Value (USD Million)

7. Global in vitro diagnostics ivd products test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global in vitro diagnostics ivd products test Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

8. Global in vitro diagnostics ivd products test Market Competition by Key Manufacturers

8.1. Global in vitro diagnostics ivd products test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global in vitro diagnostics ivd products test: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton Dickinson Company

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. bioMerieux SA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. F. Hoffmann-La Roche Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Siemens Healthcare

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Alere Inc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Beckman Coulter, Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bio-Rad Laboratories

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hologic

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Ortho Clinical Diagnostics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Roche Diagnostics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

16 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global in vitro diagnostics ivd products test Market

Figure 4: Global in vitro diagnostics ivd products test Market: Drivers

Figure 5: Global in vitro diagnostics ivd products test Market: Challenges

Figure 6: Global in vitro diagnostics ivd products test Market: Trends

Figure 7: Global in vitro diagnostics ivd products test Market: Opportunity

Figure 8: Global in vitro diagnostics ivd products test Market: Restraint

Figure 9: Global in vitro diagnostics ivd products test Market: Porter's Five Forces

Figure 10: Global in vitro diagnostics ivd products test Market Value (USD Million) By Region

Figure 11: Global in vitro diagnostics ivd products test Market Share (%) By: Regions (2024)

Figure 12: Top 5 Manufacturers

Figure 13: Top 3 Manufacturers

Figure 14: Global in vitro diagnostics ivd products test Market Value (USD Million) By Region

Figure 15: Global in vitro diagnostics ivd products test Market Share (%) By: Regions (2032)

Figure 16: Data Triangulation

List of Tables

45 items

Table 1: Market Segmentation Analysis

Table 2: Global in vitro diagnostics ivd products test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 3: Global in vitro diagnostics ivd products test Market Value (USD Million) By Region

Table 4: Global in vitro diagnostics ivd products test Market Share (%) By Region

Table 5: North America Market Value (USD Million) (2020-2024) By Country

Table 6: Europe Market Value (USD Million) (2020-2024) By Country

Table 7: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 8: South America Market Value (USD Million) (2020-2024) By Country

Table 9: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 10: Global in vitro diagnostics ivd products test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 11: Global in vitro diagnostics ivd products test Market: Profiled Players Head Office And Area Served

Table 12: Key Players Global in vitro diagnostics ivd products test Market:

Table 13: Mergers & Acquisitions, Expansion Plans

Table 14: Abbott Laboratories Basic Information And Sales Area

Table 15: Abbott Laboratories. Products Portfolio

Table 16: Becton Dickinson Company Basic Information And Sales Area

Table 17: Becton Dickinson Company. Products Portfolio

Table 18: bioMerieux SA Basic Information And Sales Area

Table 19: bioMerieux SA. Products Portfolio

Table 20: F. Hoffmann-La Roche Ltd. Basic Information And Sales Area

Table 21: F. Hoffmann-La Roche Ltd.. Products Portfolio

Table 22: Siemens Healthcare Basic Information And Sales Area

Table 23: Siemens Healthcare. Products Portfolio

Table 24: Alere Inc Basic Information And Sales Area

Table 25: Alere Inc. Products Portfolio

Table 26: Beckman Coulter, Inc. Basic Information And Sales Area

Table 27: Beckman Coulter, Inc.. Products Portfolio

Table 28: Bio-Rad Laboratories Basic Information And Sales Area

Table 29: Bio-Rad Laboratories. Products Portfolio

Table 30: Hologic Basic Information And Sales Area

Table 31: Hologic. Products Portfolio

Table 32: Ortho Clinical Diagnostics Basic Information And Sales Area

Table 33: Ortho Clinical Diagnostics. Products Portfolio

Table 34: Roche Diagnostics Basic Information And Sales Area

Table 35: Roche Diagnostics. Products Portfolio

Table 36: Global in vitro diagnostics ivd products test Market Value (USD Million) By Region

Table 37: Global in vitro diagnostics ivd products test Market Share (%) By Region (2025-2032)

Table 38: North America Market Value (USD Million) (2025-2032) By Country

Table 39: Europe Market Value (USD Million) (2025-2032) By Country

Table 40: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 41: South America Market Value (USD Million) (2025-2032) By Country

Table 42: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 43: Research Programs/Design For This Report

Table 44: Key Data Information From Secondary Sources

Table 45: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

in vitro diagnostics ivd products test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	123.40 million
Revenue forecast in 2033	268.39 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Becton Dickinson Company; bioMerieux SA; F. Hoffmann-La Roche Ltd.; Siemens Healthcare; Alere Inc; Beckman Coulter, Inc.; Bio-Rad Laboratories; Hologic; Ortho Clinical Diagnostics; Roche Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options